No Data
No Data
Sano Healthcare (688108.SH): Currently, the business mainly covers key areas of interventional treatment such as cardiovascular, cerebrovascular, and structural heart diseases
Gelonghui, May 10 | Sano Healthcare (688108.SH) said on the investor interactive platform that the company is an international company rooted in China, targeting the global market, and focusing on R&D, production and sales of high-end interventional medical devices. Currently, the company's business mainly covers key areas of interventional treatment such as cardiovascular, cerebrovascular, and structural heart diseases.
Sano Healthcare (688108): Coronary collection and intracranial stent volume are increasing rapidly, and profits are expected for the whole year
Event: The company released its 2023 annual report and 2024 quarterly report: in 2023, the company achieved operating income of 343 million yuan (+77.9%), net profit to mother of 39.63 million yuan (+75.6%), deducted from non-return
Sano Healthcare (688108): 23-year performance is in line with expectations, and the 25-year release of dense mesh stents and self-expanding drug stents can be expected
Incident: The company released its 2023 annual report, achieved revenue of 340 million yuan (+78%), realized net profit of 39.63 million yuan (year-on-year loss of 120 million yuan), and realized deduction of 49.71 million yuan. 2024 quarter
Sano Healthcare (688108): Coronary collection, rapid renewal, and sufficient room for intracranial self-inflating stents to grow
Key investment events: In 2023, the company achieved operating income of 340 million yuan (+77.99%, same ratio, same below), achieved net profit of 39.63 million yuan (reversal of loss of 123 million yuan), and realized net profit deducted from non-return to mother-
Sino Medical Sciences Technology Inc. (SHSE:688108) Surges 13%; Retail Investors Who Own 41% Shares Profited Along With Insiders
Key Insights Significant control over Sino Medical Sciences Technology by retail investors implies that the general public has more power to influence management and governance-related decisions The
Sano Healthcare (688108.SH) reported 2023 annual results with a net loss of 39.63 million yuan
Sano Healthcare (688108.SH) released its 2023 annual report. The company achieved operating income of 3 during the reporting period...
No Data